The healthcare and life sciences sectors are now bracing for global ripple effects as the Trump administration, under President Donald J. Trump’s second term, enforces a new round of tariffs targeting imports from key trade partners, including India and China. The proposed 25% tariff on
India's medical device sector is witnessing transformative changes with recent government initiatives designed to propel the country into a global manufacturing hub for medical devices. Minister Naddaji, along with Minister of State Ms. Patel and Secretary of Pharmaceuticals Dr. Arunish Chawla, recently announced new incentives
The PHD Chamber of Commerce and Industry (PHDCCI) and the Association of Indian Medical Devices (AiMed), in alliance with the Manufacturers of Imaging, Therapy and Radiology Devices Association (MITRA), the Association of Diagnostic Manufacturers of India (ADMI), and key stakeholders from the MedTech industry, held
